FR2407203A1 - Azetidinones monocycliques antibiotiques - Google Patents

Azetidinones monocycliques antibiotiques

Info

Publication number
FR2407203A1
FR2407203A1 FR7829934A FR7829934A FR2407203A1 FR 2407203 A1 FR2407203 A1 FR 2407203A1 FR 7829934 A FR7829934 A FR 7829934A FR 7829934 A FR7829934 A FR 7829934A FR 2407203 A1 FR2407203 A1 FR 2407203A1
Authority
FR
France
Prior art keywords
azetidinones
monocyclic
antibiotics
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7829934A
Other languages
English (en)
Inventor
David Kent Herron
Celia Ann Whitesitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2407203A1 publication Critical patent/FR2407203A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

L'INVENTION CONCERNE DES AZETIDINONES MONOCYCLIQUES ANTIBIOTIQUES DE FORMULE1: (CF DESSIN DANS BOPI) OU R EST UN GROUPEMENT DE FORMULE A OU B CI-DESSUS, OU R EST UN ATOME D'HYDROGENE OU UN GROUPEMENT PROTECTEUR ET X EST UN GROUPEMENT ACYLOXY EN C-C, HYDROXY, ALCOXY EN C-C, BENZYLOXY OU PYRIDINIUM; ET R EST UN ATOME D'HYDROGENE OU UN GROUPEMENT ACYCLE, AINSI QUE LEURS SELS PHARMACEUTIQUEMENT ACCEPTABLES. UTILISATION DES NOUVEAUX COMPOSES COMME ANTIBIOTIQUES IN VIVO ET IN VITRO.
FR7829934A 1977-10-26 1978-10-20 Azetidinones monocycliques antibiotiques Withdrawn FR2407203A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/845,766 US4195021A (en) 1977-10-26 1977-10-26 1,3-Disubstituted 2-azetidinone antibitotics

Publications (1)

Publication Number Publication Date
FR2407203A1 true FR2407203A1 (fr) 1979-05-25

Family

ID=25296053

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7829934A Withdrawn FR2407203A1 (fr) 1977-10-26 1978-10-20 Azetidinones monocycliques antibiotiques

Country Status (7)

Country Link
US (1) US4195021A (fr)
EP (1) EP0001715A3 (fr)
JP (1) JPS5470256A (fr)
BE (1) BE871401A (fr)
FR (1) FR2407203A1 (fr)
GB (1) GB2008574A (fr)
IL (1) IL55779A0 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472300A (en) * 1977-12-07 1984-09-18 Fujisawa Pharmaceutical Co., Ltd. Azetidinone derivatives and process for preparation thereof
US4263306A (en) * 1979-08-01 1981-04-21 Merck & Co., Inc. 3-N-Pyridinium nocardicin and antibiotic composition thereof
US4337197A (en) 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
US4595532A (en) * 1983-02-02 1986-06-17 University Of Notre Dame Du Lac N-(substituted-methyl)-azetidin-2-ones
GR81665B (fr) * 1983-02-02 1984-12-12 Univ Notre Dame Du Lac
UA77200C2 (en) 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
CL2004000016A1 (es) * 2003-01-21 2005-04-15 Wyeth Corp Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2278335A1 (fr) * 1974-07-04 1976-02-13 Fujisawa Pharmaceutical Co Derives d'azetidinones et leurs procedes de preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2143211B1 (fr) * 1971-06-24 1975-10-31 Fujisawa Pharmaceutical Co
CH618161A5 (en) * 1974-07-04 1980-07-15 Fujisawa Pharmaceutical Co Process for the preparation of azetidinone derivatives
GB1570278A (en) * 1975-10-06 1980-06-25 Fujisawa Pharmaceutical Co O-substituted-2-azetidinone derivatives and the preparation thereof
JPS6019315B2 (ja) * 1976-01-23 1985-05-15 塩野義製薬株式会社 アゼチジノン化合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2278335A1 (fr) * 1974-07-04 1976-02-13 Fujisawa Pharmaceutical Co Derives d'azetidinones et leurs procedes de preparation

Also Published As

Publication number Publication date
EP0001715A3 (fr) 1979-05-16
GB2008574A (en) 1979-06-06
US4195021A (en) 1980-03-25
BE871401A (fr) 1979-04-20
JPS5470256A (en) 1979-06-05
EP0001715A2 (fr) 1979-05-02
IL55779A0 (en) 1978-12-17

Similar Documents

Publication Publication Date Title
FR2387938A1 (fr) Fluorures o-carbonyles a-carboxyles fluores et leur preparation
FR2387941A1 (fr) Homologue de la somatostatine, ses intermediaires de preparation, et son utilisation comme medicament
DE3785136D1 (de) Arzneimittel zur inhibition von hautfalte.
FR2391723A1 (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
FI860969A (fi) Cyklopenta(d)pyrimidinderivat, deras framstaellning och anvaendning.
FR2407203A1 (fr) Azetidinones monocycliques antibiotiques
FR2409989A1 (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique
FR2430409A1 (fr) Phenethanolamines et leur utilisation comme potentialisateurs des medicaments destructeurs des cellules cancereuses
FR2448899A1 (fr) Utilisation therapeutique de l'acide 6,7-dichloro-3,4-dihydro-3-oxo-2-quinoxalinecarboxylique et de ses esters
FR2413370A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
FR2451191A1 (fr) Compositions therapeutiques a base de derives hydroxyles de l'isopropylamino-2 pyrimidine
FR2395272A1 (fr) Nouveaux medicaments derives de l'acide amidinopenicillanique
FR2450820A1 (fr) Nouveaux derives d'acides 1- (o-mercaptoacyl) -4,5-dihydropyrazole-5-carboxyliques, utiles notamment comme agents hypotenseurs, et leur procede de preparation
GB1153578A (en) Phenyl-Isopropylamine Derivatives
ATE41146T1 (de) Irreversible dopamin-b-hydroxylase-inhibitoren.
KR920004387A (ko) 진통제 및 피부질환 치료용 국소용 소염제로서의 4-치환된 디하이드로피리도[4,3-d]피리미딘
FR2375253A1 (fr) Preparations de g-lactones d'acides 7x-(alcoxycarbonyl)-6x -alkyl/halog 17-hydroxy-3-oxo-17a -pregn-4-ene-21-carboxyliques, des acides 21-carboxyliques correspondants, de leurs sels et esters, et leur utilisation therapeutique comme diuretiques
SE8005778L (sv) Dermatologisk beredning jemte sett for dess framstellning
FR2404627A1 (fr) Dichloracetamides disubstitues a l'azote, leur preparation et leur utilisation, notamment dans le traitement des amibiases
FR2421179A1 (fr) 3-0-(b-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques
FR2381767A1 (fr) Pyrroloquinoxalinones et diones subsituees et leur utilisation comme medicaments
ES2002207A6 (es) Un metodo para producir derivados de glucosilmoranolina
FR2405926A1 (fr) (asn2)-thymosine a1 et procede de preparation
FR2389631A1 (fr)
FR2451375A1 (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse